Skip to content

RADX

Radiopharm Theranostics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$1.65
−4.62%
Ask drillr

Margins

Gross margin
-38.6%
EBITDA margin
-2502.5%
EBIT margin
-2550.7%
Net margin
-1993.2%
FCF margin
-805.8%
-223.0%
Return on equity
-91.5%
Return on assets
-285.4%
Return on invested capital
0.04x
Asset turnover
-$38.6M
Cash from operations
$0.20
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026